康邁德公司
US ˙ NYSE ˙ US2074101013

SecurityCNMD / CONMED Corporation
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership3,788 shares
Latest Disclosed Value $ 425,000
Advisor Group, Inc. reports 29.95% increase in ownership of CNMD / CONMED Corporation

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 3,788 shares of CONMED Corporation (US:CNMD) valued at $423,612 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 2,915 shares of CONMED Corporation. This represents a change in shares of 29.95% during the quarter. The current value of the position is $133,186 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F CONMED COM 207410101 3,788 873 29.95 425 51.25 0.0029
2019-11-13 2019-09-30 13F CONMED COM 207410101 2,915 -15 -0.51 281 11.95 0.0021
2019-07-31 2019-06-30 13F CONMED COM 207410101 2,930 1,179 67.33 251 71.92 0.0019
2019-05-09 2019-03-31 13F CONMED COM 207410101 1,751 -558 -24.17 146 -1.35 0.0012
2019-02-11 2018-12-31 13F CONMED COM 207410101 2,309 59 2.62 148 -16.85 0.0015
2018-11-14 2018-09-30 13F CONMED COM 207410101 2,250 1,620 257.14 178 286.96 0.0018
2018-08-13 2018-06-30 13F CONMED COM 207410101 630 0 0.00 46 15.00 0.0006
2018-05-15 2018-03-31 13F CONMED COM 207410101 630 -100 -13.70 40 5.26 0.0005
2018-02-14 2017-12-31 13F CONMED COM 207410101 730 0 0.00 38 -2.56 0.0005
2017-11-06 2017-09-30 13F CONMED COM 207410101 730 0 0.00 39 2.63 0.0006
2017-11-03 2017-06-30 13F/A-1 CONMED COM 207410101 730 -50 -6.41 38 11.76 0.0007
2017-08-11 2017-06-30 13F CONMED COM 207410101 730 -50 38
2017-11-02 2017-03-31 13F/A-1 CONMED COM 207410101 780 100 14.71 34 13.33 0.0007
2017-05-15 2017-03-31 13F CONMED COM 207410101 780 100 34
2017-11-02 2016-12-31 13F/A-1 CONMED COM 207410101 680 380 126.67 30 150.00 0.0007
2017-01-31 2016-12-31 13F CONMED COM 207410101 680 380 30
2017-11-02 2016-09-30 13F/A-1 CONMED COM 207410101 300 0 12 0.0003
2016-11-08 2016-09-30 13F CONMED COM 207410101 300 12
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.